Skip to content
In English |
En español
Search
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -2 of 2
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
5/30/2006
 
First Published:
1/1/1998
1.
Phase III Study of the Prophylactic Use of Oral Pilocarpine to Reduce Hyposalivation and Mucositis Associated with Curative Radiation Therapy in Patients with Head and Neck Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Supportive care
Closed
18 and over
NCI
RTOG-9709
NCI-P97-0121, NCT00003139
Last Modified:
5/31/2007
 
First Published:
2/1/1999
2.
Phase III Randomized Study of Oral Pilocarpine for Patients with Opioid-Induced Dry Mouth (Summary Last Modified 06/2000)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Supportive care
Closed
16 and over
Pharmaceutical / Industry
CAN-NCIC-SC16
P-UPJOHN-CAN-NCIC-SC16, NCT00003686, SC16
Select All on One Page
NCI Home
|
Text-Only Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute